Skip to main content
SpringerLink
Log in

Development of pleural and pericardial effusions during itraconazole therapy of pulmonary aspergillosis

  • Letters
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Sharkey PK, Rinaldi MG, Dunn JF, Hardin TC, Fetchick RJ, Graybill JR High-dose itraconazole in the treatment of severe mycoses. Antimicrobial Agents and Chemotherapy 1991, 35: 707–713.

    PubMed  Google Scholar 

  2. Denning DW Itraconazol bei systemischen Pilzinfektionen. Medizinische Klinik 1991, 86, Supplement 1: 3–4.

    PubMed  Google Scholar 

  3. Hostetler JS, Stevens DA Die Behandlung von Aspergillosen, Kryptokokken und Histoplasmosen bei immungeschwächten Patienten. Medizinische Klinik 1991, 86, Supplement 1: 13–19.

    PubMed  Google Scholar 

  4. Bayles MAH Tropische Mykosen. Medizinische Klinik 1991, 86, Supplement 1: 23–25.

    Google Scholar 

  5. Viviani MA Mykosen als opportunistische Infektionen bei AIDS-Patienten. Medizinische Klinik 1991, 86, Supplement 1: 19–22.

    PubMed  Google Scholar 

  6. Dismukes WE, Bradsher RW, Cloud GC, Kauffman CA, Chapman SW, George RB, Stevens DA, Girard WM, Saag MS, Bowles-Patton C, andothers in the NIAID Mycoses Study Group Itraconazole therapy for blastomycosis and histoplasmosis. American Journal of Medicine 1992, 93: 489–497.

    Article  PubMed  Google Scholar 

  7. Saag MS, Dismukes WE Azole antifungal agents emphasis on new triazoles. Antimicrobial Agents and Chemotherapy 1988, 32: 1–8.

    PubMed  Google Scholar 

  8. Tucker RM, Hag Y, Denning DW, Stevens DA Adverse events associated with itraconazole in 189 patients on chronic therapy. Journal of Antimicrobial Chemotherapy 1990, 26: 561–566.

    PubMed  Google Scholar 

  9. Van Cutsem I In-vitro und in-vivo Aktivität von Itraconazol. Medizinische Klinik 1991, 86, Supplement 1: 5–8.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Section of Immunology and Infectious Diseases, Department of Pulmonary Medicine, Zehlendorf Hospital, Zum Heckeshorn 33, 14109, Berlin, Germany

    J. Günther, H. Lode, M. Raffenberg & T. Schaberg

Authors
  1. J. Günther
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Lode
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Raffenberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. T. Schaberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Günther, J., Lode, H., Raffenberg, M. et al. Development of pleural and pericardial effusions during itraconazole therapy of pulmonary aspergillosis. Eur. J. Clin. Microbiol. Infect. Dis. 12, 723–724 (1993). https://doi.org/10.1007/BF02009391

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02009391

Keywords

Search

Navigation